Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPMO.L Regulatory News (PMO)

  • There is currently no data for PMO

Statement re Market speculation

14 Jan 2019 08:41

RNS Number : 9925M
Premier Oil PLC
14 January 2019
 

("Premier" or "the Group")

Statement re: Market speculation

14 January 2019

 

Premier notes the press speculation regarding the possibility of the Group making a UK acquisition.

Premier will continue to look at opportunities to acquire UK North Sea assets in line with the Group's stated strategy. There is no guarantee that the Group will bid in any process or that any process will complete. 

Specifically, no firm decision has been taken to bid for all or any of the assets currently being marketed by Chevron and how, in the event that the Group were to be successful, the acquisition of such assets would be financed.

Current operational performance remains strong with production in the first two weeks of January averaging above 90 kboepd.

 

Enquiries

 

 

Premier Oil plc

 

Tel: 020 7730 1111

Tony Durrant, Chief Executive

 

 

Richard Rose, Finance Director

 

 

 

Camarco

 

Tel: 020 3757 4983

Billy Clegg

Georgia Edmonds

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRGIGDBIXBBGCS
Date   Source Headline
27th Mar 20175:59 pmRNSDirector/PDMR Shareholding
24th Mar 20172:00 pmRNSHolding(s) in Company
23rd Mar 20177:00 amRNSRevised conversion price for convertible bonds
15th Mar 20177:00 amRNSRefinancing update
14th Mar 20172:00 pmRNSHolding(s) in Company
9th Mar 20177:01 amRNSFinal Results
9th Mar 20177:00 amRNSRefinancing update
3rd Mar 20173:00 pmRNSHolding(s) in Company
3rd Mar 20179:00 amRNSHolding(s) in Company
2nd Mar 20175:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20175:00 pmRNSHolding(s) in Company
2nd Mar 20173:00 pmRNSHolding(s) in Company
1st Mar 20174:30 pmRNSHolding(s) in Company
1st Mar 20177:00 amRNSRefinancing update
24th Feb 20172:28 pmRNSShare price weakness
3rd Feb 20177:00 amRNSAnnouncement of the proposed refinancing
2nd Feb 20175:00 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSDeferral of Financial Covenant Test
12th Jan 201712:00 pmRNSHolding(s) in Company
12th Jan 20177:00 amRNSTrading and Operations Update
5th Jan 201712:00 pmRNSDirector/PDMR Shareholding
3rd Jan 201712:00 pmRNSHolding(s) in Company
3rd Jan 201712:00 pmRNSBlock listing Interim Review
29th Dec 20167:00 amRNSDeferral of Financial Covenant Test
15th Dec 20165:10 pmRNSHolding(s) in Company
15th Dec 201612:00 pmRNSHolding(s) in Company
2nd Dec 20163:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20169:00 amRNSTotal Voting Rights
30th Nov 20167:00 amRNSDeferral of Financial Covenant Test
18th Nov 201610:00 amRNSNotification of Change of Auditor
17th Nov 20167:00 amRNSTrading and Operations Update
14th Nov 201612:32 pmRNSTR-1: Notification of Interest
8th Nov 20161:01 pmRNSMarket speculation
8th Nov 201611:00 amRNSHolding(s) in Company
2nd Nov 201612:00 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSDeferral of Financial Covenant Test
24th Oct 20164:00 pmRNSHolding(s) in Company
21st Oct 20162:00 pmRNSHolding(s) in Company
4th Oct 20163:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20169:00 amRNSTotal Voting Rights
3rd Oct 20167:00 amRNSDeferral of financial covenant test
2nd Sep 20163:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20163:00 pmRNSHolding(s) in Company
1st Sep 20167:00 amRNSLender Discussions Update
19th Aug 201612:34 pmRNSCorrection: Half-year Report
18th Aug 20167:00 amRNSHalf-year Report
17th Aug 201610:00 amRNSHolding(s) in Company
5th Aug 20165:00 pmRNSHolding(s) in Company
5th Aug 20167:00 amRNSBagpuss well result
3rd Aug 20165:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.